{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:50:33Z","timestamp":1759942233241},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:00:00Z","timestamp":1495843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11011-017-0035-z","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T23:15:57Z","timestamp":1495840557000},"page":"1507-1518","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Acute and long-term effects of intracerebroventricular administration of \u03b1-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors"],"prefix":"10.1007","volume":"32","author":[{"given":"Luciane","family":"Taschetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselli","family":"Scaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo G.","family":"Zapelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ndrea C.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Strapazzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa M.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gislaine Z.","family":"R\u00e9us","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Dal-Pizzol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia F.","family":"Schuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio L.","family":"Streck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,27]]},"reference":[{"key":"35_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"key":"35_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s12031-013-0061-1","volume":"51","author":"KH Alzoubi","year":"2013","unstructured":"Alzoubi KH, Khabour OF, Alhaidar IA, Aleisa AM, Alkadhi KA (2013) Diabetes impairs synaptic plasticity in the superior cervical ganglion: possible role for BDNF and oxidative stress. J Mol Neurosci 51:763\u2013770. doi: 10.1007\/s12031-013-0061-1","journal-title":"J Mol Neurosci"},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2010.02.018","volume":"1324","author":"AU Amaral","year":"2010","unstructured":"Amaral AU, Leipnitz G, Fernandes CG, Seminotti B, Schuck PF, Wajner M (2010) Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75\u201384. doi: 10.1016\/j.brainres.2010.02.018","journal-title":"Brain Res"},{"key":"35_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/9780470110539.ch5","volume":"32","author":"JV Bannister","year":"1987","unstructured":"Bannister JV, Calabrese L (1987) Assays for superoxide dismutase. Methods Biochem Anal 32:279\u2013312","journal-title":"Methods Biochem Anal"},{"key":"35_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.CCM.0000150741.12906.BD","volume":"33","author":"T Barichello","year":"2005","unstructured":"Barichello T, Martins MR, Reinke A, Feier G, Ritter C, Quevedo J, Dal-Pizzol F (2005) Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med 33:221\u2013223","journal-title":"Crit Care Med"},{"key":"35_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijdevneu.2007.05.004","volume":"25","author":"AG Barschak","year":"2007","unstructured":"Barschak AG et al (2007) Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treatment. Int J Dev Neurosci 25:335\u2013338. doi: 10.1016\/j.ijdevneu.2007.05.004","journal-title":"Int J Dev Neurosci"},{"key":"35_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clinbiochem.2007.11.015","volume":"41","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR (2008a) Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem 41:317\u2013324. doi: 10.1016\/j.clinbiochem.2007.11.015","journal-title":"Clin Biochem"},{"key":"35_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","volume":"23","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR (2008b) Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis 23:71\u201380. doi: 10.1007\/s11011-007-9077-y","journal-title":"Metab Brain Dis"},{"key":"35_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.clinbiochem.2008.12.005","volume":"42","author":"AG Barschak","year":"2009","unstructured":"Barschak AG et al (2009) Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Clin Biochem 42:462\u2013466. doi: 10.1016\/j.clinbiochem.2008.12.005","journal-title":"Clin Biochem"},{"key":"35_CR10","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.neuropsychologia.2006.04.001","volume":"44","author":"P Bitsios","year":"2006","unstructured":"Bitsios P, Giakoumaki SG, Theou K, Frangou S (2006) Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males. Neuropsychologia 44:2494\u20132499. doi: 10.1016\/j.neuropsychologia.2006.04.001","journal-title":"Neuropsychologia"},{"key":"35_CR11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/BF00443107","volume":"148","author":"M Borglund","year":"1989","unstructured":"Borglund M, Sjoblad S, Akesson B (1989) Effect of selenium supplementation on the distribution of selenium among plasma proteins of a patient with maple syrup urine disease. Euro J Pediatr 148:767\u2013769","journal-title":"Euro J Pediatr"},{"key":"35_CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234\u2013258","journal-title":"Psychopharmacology"},{"key":"35_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS (2005) Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 20:155\u2013167","journal-title":"Metab Brain Dis"},{"key":"35_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/A:1021694307672","volume":"29","author":"RE Brown","year":"1999","unstructured":"Brown RE, Corey SC, Moore AK (1999) Differences in measures of exploration and fear in MHC-congenic C57BL\/6J and B6-H-2K mice. Behav Genet 29:263\u2013271. doi: 10.1023\/A:1021694307672","journal-title":"Behav Genet"},{"key":"35_CR15","first-page":"1971","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2001","unstructured":"Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1971\u20132005"},{"key":"35_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","volume":"48","author":"ML Circu","year":"2010","unstructured":"Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749\u2013762. doi: 10.1016\/j.freeradbiomed.2009.12.022","journal-title":"Free Radic Biol Med"},{"key":"35_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1385\/MB:26:3:249","volume":"26","author":"AR Collins","year":"2004","unstructured":"Collins AR (2004) The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249\u2013261. doi: 10.1385\/MB:26:3:249","journal-title":"Mol Biotechnol"},{"key":"35_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1471-4914(03)00031-5","volume":"9","author":"I Dalle-Donne","year":"2003","unstructured":"Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A (2003) Protein carbonylation in human diseases. Trends Mol Med 9:169\u2013176","journal-title":"Trends Mol Med"},{"key":"35_CR19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-3476(72)80301-9","volume":"81","author":"J Dancis","year":"1972","unstructured":"Dancis J, Hutzler J, Snyderman SE, Cox RP (1972) Enzyme activity in classical and variant forms of maple syrup urine disease. J Pediatr 81:312\u2013320","journal-title":"J Pediatr"},{"key":"35_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pbb.2003.10.013","volume":"77","author":"VV Castro de","year":"2004","unstructured":"de Castro VV, de Boer MA, Diligenti F, Brinco F, Mallmann F, Mello CF, Wajner M (2004) Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats. Pharmacol Biochem Behav 77:183\u2013190","journal-title":"Pharmacol Biochem Behav"},{"key":"35_CR21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","volume":"186","author":"HH Draper","year":"1990","unstructured":"Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421\u2013431","journal-title":"Methods Enzymol"},{"key":"35_CR22","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1073\/pnas.94.8.4086","volume":"94","author":"LL Dugan","year":"1997","unstructured":"Dugan LL, Creedon DJ, Johnson EM Jr, Holtzman DM (1997) Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 94:4086\u20134091","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/abbi.2001.2292","volume":"388","author":"P Evelson","year":"2001","unstructured":"Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi EA (2001) Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 388:261\u2013266. doi: 10.1006\/abbi.2001.2292","journal-title":"Arch Biochem Biophys"},{"key":"35_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","volume":"17","author":"FU Fontella","year":"2002","unstructured":"Fontella FU, Gassen E, Pulrolnik V, Wannmacher CM, Klein AB, Wajner M, Dutra-Filho CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47\u201354","journal-title":"Metab Brain Dis"},{"key":"35_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-3806(02)00578-3","volume":"139","author":"C Funchal","year":"2002","unstructured":"Funchal C et al (2002) Alpha-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamatergic receptors. Brain Res Dev Brain Res 139:267\u2013276","journal-title":"Brain Res Dev Brain Res"},{"key":"35_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.neuint.2006.05.007","volume":"49","author":"C Funchal","year":"2006","unstructured":"Funchal C et al (2006) Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease. Neurochem Int 49:640\u2013650. doi: 10.1016\/j.neuint.2006.05.007","journal-title":"Neurochem Int"},{"key":"35_CR27","first-page":"175","volume":"104","author":"FK Graham","year":"1975","unstructured":"Graham FK, Putnam LE, Leavitt LA (1975) Lead-stimulation effects of human cardiac orienting and blink reflexes. J Exp Psychol Hum Percept Perform 104:175\u2013182","journal-title":"J Exp Psychol Hum Percept Perform"},{"key":"35_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tips.2010.12.002","volume":"32","author":"B Halliwell","year":"2011","unstructured":"Halliwell B (2011) Free radicals and antioxidants - quo vadis? Trends Pharmacol Sci 32:125\u2013130. doi: 10.1016\/j.tips.2010.12.002","journal-title":"Trends Pharmacol Sci"},{"key":"35_CR29","volume-title":"Free radicals in biology and medicine vol 4","author":"B Halliwell","year":"2006","unstructured":"Halliwell B, Gutteridge JMC (2006) Free radicals in biology and medicine vol 4. Oxford University Press, Oxford"},{"key":"35_CR30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1469-8986.3840669","volume":"38","author":"EA Hazlett","year":"2001","unstructured":"Hazlett EA, Dawson ME, Schell AM, Nuechterlein KH (2001) Attentional stages of information processing during a continuous performance test: a startle modification analysis. Psychophysiology 38:669\u2013677","journal-title":"Psychophysiology"},{"key":"35_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1037\/0033-295X.87.2.175","volume":"87","author":"HS Hoffman","year":"1980","unstructured":"Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175\u2013189","journal-title":"Psychol Rev"},{"key":"35_CR32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-113-28456","volume":"113","author":"RK Howell","year":"1963","unstructured":"Howell RK, Lee M (1963) Influence of alpha-ketoacids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660\u2013663","journal-title":"Proc Soc Exp Biol Med"},{"key":"35_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12098-012-0850-5","volume":"80","author":"P Jain","year":"2013","unstructured":"Jain P, Sharma S, Sankhyan N, Gupta N, Kabra M, Gulati S (2013) Imaging in neonatal maple syrup urine disease. Indian J Pediatr 80:87\u201388. doi: 10.1007\/s12098-012-0850-5","journal-title":"Indian J Pediatr"},{"key":"35_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00234-003-0955-7","volume":"45","author":"W Jan","year":"2003","unstructured":"Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM (2003) MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 45:393\u2013399. doi: 10.1007\/s00234-003-0955-7","journal-title":"Neuroradiology"},{"key":"35_CR35","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1042\/bst026s341","volume":"26","author":"P Jouvet","year":"1998","unstructured":"Jouvet P et al (1998) Maple syrup urine disease metabolites induce apoptosis in neural cells without cytochrome c release or changes in mitochondrial membrane potential. Biochem Soc Trans 26:S341","journal-title":"Biochem Soc Trans"},{"key":"35_CR36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1749-6632.2000.tb05604.x","volume":"926","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Kozma M, Mehmet H (2000a) Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids. Ann N Y Acad Sci 926:116\u2013121","journal-title":"Ann N Y Acad Sci"},{"key":"35_CR37","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"P Jouvet","year":"2000","unstructured":"Jouvet P et al (2000b) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919\u20131932","journal-title":"Mol Biol Cell"},{"key":"35_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneumeth.2005.07.015","volume":"151","author":"B Kinkead","year":"2006","unstructured":"Kinkead B, Selz KA, Owens MJ, Mandell AJ (2006) Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism. J Neurosci Methods 151:68\u201381. doi: 10.1016\/j.jneumeth.2005.07.015","journal-title":"J Neurosci Methods"},{"key":"35_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tibs.2006.11.003","volume":"32","author":"HN Kirkman","year":"2007","unstructured":"Kirkman HN, Gaetani GF (2007) Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci 32:44\u201350. doi: 10.1016\/j.tibs.2006.11.003","journal-title":"Trends Biochem Sci"},{"key":"35_CR40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10545-012-9582-y","volume":"36","author":"D Klee","year":"2013","unstructured":"Klee D et al (2013) Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis 36:945\u2013953. doi: 10.1007\/s10545-012-9582-y","journal-title":"J Inherit Metab Dis"},{"key":"35_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/74994","volume":"6","author":"G Kroemer","year":"2000","unstructured":"Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513\u2013519. doi: 10.1038\/74994","journal-title":"Nat Med"},{"key":"35_CR42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0076-6879(94)33040-9","volume":"233","author":"RL Levine","year":"1994","unstructured":"Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346\u2013357","journal-title":"Methods Enzymol"},{"key":"35_CR43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00445606","volume":"128","author":"I Lombeck","year":"1978","unstructured":"Lombeck I et al (1978) The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease. Euro J Pediatr 128:213\u2013223","journal-title":"Euro J Pediatr"},{"key":"35_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1385\/NMM:2:2:215","volume":"2","author":"MP Mattson","year":"2002","unstructured":"Mattson MP, Liu D (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. NeuroMolecular Med 2:215\u2013231. doi: 10.1385\/NMM:2:2:215","journal-title":"NeuroMolecular Med"},{"key":"35_CR45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1542\/peds.23.2.348","volume":"23","author":"JH Menkes","year":"1959","unstructured":"Menkes JH (1959) Maple syrup disease; isolation and identification of organic acids in the urine. Pediatrics 23:348\u2013353","journal-title":"Pediatrics"},{"key":"35_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijdevneu.2012.10.109","volume":"31","author":"CP Mescka","year":"2013","unstructured":"Mescka CP et al (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. Int J Dev Neurosci 31:21\u201324. doi: 10.1016\/j.ijdevneu.2012.10.109","journal-title":"Int J Dev Neurosci"},{"key":"35_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mrfmmm.2015.03.008","volume":"775","author":"CP Mescka","year":"2015","unstructured":"Mescka CP et al (2015) L-Carnitine supplementation decreases DNA damage in treated MSUD patients. Mutat Res 775:43\u201347. doi: 10.1016\/j.mrfmmm.2015.03.008","journal-title":"Mutat Res"},{"key":"35_CR48","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","volume":"53","author":"E Niedzielska","year":"2016","unstructured":"Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53:4094\u20134125. doi: 10.1007\/s12035-015-9337-5","journal-title":"Mol Neurobiol"},{"issue":"Suppl 1","key":"35_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1471-4159.2009.05897.x","volume":"109","author":"K Niizuma","year":"2009","unstructured":"Niizuma K, Endo H, Chan PH (2009) Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109(Suppl 1):133\u2013138. doi: 10.1111\/j.1471-4159.2009.05897.x","journal-title":"J Neurochem"},{"key":"35_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1162\/153840902753658329","volume":"2002","author":"G Olivieri","year":"2002","unstructured":"Olivieri G, Otten U, Meier F, Baysang G, Dimitriades-Schmutz B, Muller-Spahn F, Savaskan E (2002) Oxidative stress modulates tyrosine kinase receptor a and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells. Neurol Clin Neurophysiol 2002:2\u201310. doi: 10.1162\/153840902753658329","journal-title":"Neurol Clin Neurophysiol"},{"key":"35_CR51","volume-title":"The rat brain in stereotaxic coordinates vol 2","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates vol 2. Academic Press, San Diego"},{"key":"35_CR52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(01)01184-2","volume":"50","author":"W Perry","year":"2001","unstructured":"Perry W, Minassian A, Feifel D, Braff DL (2001) Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 50:418\u2013424","journal-title":"Biol Psychiatry"},{"key":"35_CR53","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.biopsych.2005.09.025","volume":"61","author":"W Perry","year":"2007","unstructured":"Perry W, Minassian A, Lopez B, Maron L, Lincoln A (2007) Sensorimotor gating deficits in adults with autism. Biol Psychiatry 61:482\u2013486. doi: 10.1016\/j.biopsych.2005.09.025","journal-title":"Biol Psychiatry"},{"key":"35_CR54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"35_CR55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00008877-199712000-00006","volume":"8","author":"J Quevedo","year":"1997","unstructured":"Quevedo J, Vianna M, Zanatta MS, Roesler R, Izquierdo I, Jerusalinsky D, Quillfeldt JA (1997) Involvement of mechanisms dependent on NMDA receptors, nitric oxide and protein kinase a in the hippocampus but not in the caudate nucleus in memory. Behav Pharmacol 8:713\u2013717","journal-title":"Behav Pharmacol"},{"key":"35_CR56","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1101\/lm.6.6.600","volume":"6","author":"J Quevedo","year":"1999","unstructured":"Quevedo J, Vianna MR, Roesler R, de-Paris F, Izquierdo I, Rose SP (1999) Two time windows of anisomycin-induced amnesia for inhibitory avoidance training in rats: protection from amnesia by pretraining but not pre-exposure to the task apparatus. Learn Mem 6:600\u2013607","journal-title":"Learn Mem"},{"issue":"Suppl 3","key":"35_CR57","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.3233\/JAD-132738","volume":"42","author":"E Radi","year":"2014","unstructured":"Radi E, Formichi P, Battisti C, Federico A (2014) Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 42(Suppl 3):S125\u2013S152. doi: 10.3233\/JAD-132738","journal-title":"J Alzheimers Dis"},{"key":"35_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA et al (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114\u2013124. doi: 10.1007\/s11064-007-9423-9","journal-title":"Neurochem Res"},{"key":"35_CR59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12035-012-8243-3","volume":"45","author":"G Scaini","year":"2012","unstructured":"Scaini G et al (2012a) Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease. Mol Neurobiol 45:279\u2013286. doi: 10.1007\/s12035-012-8243-3","journal-title":"Mol Neurobiol"},{"key":"35_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ymgme.2012.04.009","volume":"106","author":"G Scaini","year":"2012","unstructured":"Scaini G et al (2012b) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106:169\u2013174. doi: 10.1016\/j.ymgme.2012.04.009","journal-title":"Mol Genet Metab"},{"key":"35_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbr.2012.03.004","volume":"231","author":"G Scaini","year":"2012","unstructured":"Scaini G et al (2012c) Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease. Behav Brain Res 231:92\u201396. doi: 10.1016\/j.bbr.2012.03.004","journal-title":"Behav Brain Res"},{"key":"35_CR62","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10545-012-9549-z","volume":"36","author":"G Scaini","year":"2013","unstructured":"Scaini G et al (2013a) Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model. J Inherit Metab Dis 36:721\u2013730. doi: 10.1007\/s10545-012-9549-z","journal-title":"J Inherit Metab Dis"},{"key":"35_CR63","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12035-013-8447-1","volume":"48","author":"G Scaini","year":"2013","unstructured":"Scaini G et al (2013b) Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus. Mol Neurobiol 48:581\u2013589. doi: 10.1007\/s12035-013-8447-1","journal-title":"Mol Neurobiol"},{"key":"35_CR64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/8904_2013_274","volume":"13","author":"G Scaini","year":"2014","unstructured":"Scaini G et al (2014) Behavioral responses in rats submitted to chronic administration of branched-chain amino acids. JIMD reports 13:159\u2013167. doi: 10.1007\/8904_2013_274","journal-title":"JIMD reports"},{"key":"35_CR65","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11064-015-1541-1","volume":"40","author":"G Scaini","year":"2015","unstructured":"Scaini G et al (2015) Acute Administration of Branched-Chain Amino Acids Increases the pro-BDNF\/Total-BDNF ratio in the rat brain. Neurochem Res 40:885\u2013893. doi: 10.1007\/s11064-015-1541-1","journal-title":"Neurochem Res"},{"key":"35_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","volume":"82","author":"S Schonberger","year":"2004","unstructured":"Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69\u201375. doi: 10.1016\/j.ymgme.2004.01.016","journal-title":"Mol Genet Metab"},{"key":"35_CR67","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2003.09.010","volume":"1639","author":"AM Sgaravatti","year":"2003","unstructured":"Sgaravatti AM et al (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232\u2013238","journal-title":"Biochim Biophys Acta"},{"key":"35_CR68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","volume":"175","author":"NP Singh","year":"1988","unstructured":"Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184\u2013191","journal-title":"Exp Cell Res"},{"key":"35_CR69","first-page":"3","volume":"55","author":"SE Snyderman","year":"1964","unstructured":"Snyderman SE, Holt LE Jr (1964) Maple syrup urine disease. J Maine Med Assoc 55:3\u20135","journal-title":"J Maine Med Assoc"},{"key":"35_CR70","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1542\/peds.34.4.454","volume":"34","author":"SE Snyderman","year":"1964","unstructured":"Snyderman SE, Norton PM, Roitman E, Holt LE Jr (1964) Maple syrup urine disease, with particular reference to Dietotherapy. Pediatrics 34:454\u2013472","journal-title":"Pediatrics"},{"key":"35_CR71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","volume":"51","author":"NR Swerdlow","year":"1994","unstructured":"Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139\u2013154","journal-title":"Arch Gen Psychiatry"},{"key":"35_CR72","first-page":"109","volume":"53","author":"T Taketomi","year":"1983","unstructured":"Taketomi T, Kunishita T, Hara A, Mizushima S (1983) Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease. Jpn J Exp Med 53:109\u2013116","journal-title":"Jpn J Exp Med"},{"key":"35_CR73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(00)00402-0","volume":"181","author":"RG Tavares","year":"2000","unstructured":"Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS (2000) Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181:44\u201349","journal-title":"J Neurol Sci"},{"key":"35_CR74","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","volume":"35","author":"RR Tice","year":"2000","unstructured":"Tice RR et al (2000) Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206\u2013221","journal-title":"Environ Mol Mutagen"},{"key":"35_CR75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01800354","volume":"15","author":"E Treacy","year":"1992","unstructured":"Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR (1992) Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J Inherit Metab Dis 15:121\u2013135","journal-title":"J Inherit Metab Dis"},{"key":"35_CR76","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0006-291X(83)90799-4","volume":"114","author":"D Tribble","year":"1983","unstructured":"Tribble D, Shapira R (1983) Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease. Biochem Biophys Res Commun 114:440\u2013446","journal-title":"Biochem Biophys Res Commun"},{"key":"35_CR77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1101\/lm.34600","volume":"7","author":"MR Vianna","year":"2000","unstructured":"Vianna MR et al (2000) Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem 7:333\u2013340","journal-title":"Learn Mem"},{"key":"35_CR78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/adc.80.6.579","volume":"80","author":"M Wajner","year":"1999","unstructured":"Wajner M, Vargas CR (1999) Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises. Arch Dis Child 80:579","journal-title":"Arch Dis Child"},{"key":"35_CR79","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1005668431926","volume":"23","author":"M Wajner","year":"2000","unstructured":"Wajner M, Coelho DM, Barschak AG, Araujo PR, Pires RF, Lulhier FL, Vargas CR (2000) Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises. J Inherit Metab Dis 23:505\u2013512","journal-title":"J Inherit Metab Dis"},{"key":"35_CR80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/B:BOLI.0000037353.13085.e2","volume":"27","author":"M Wajner","year":"2004","unstructured":"Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427\u2013448. doi: 10.1023\/B:BOLI.0000037353.13085.e2","journal-title":"J Inherit Metab Dis"},{"key":"35_CR81","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11011-015-9768-8","volume":"31","author":"MS Wisniewski","year":"2016","unstructured":"Wisniewski MS et al (2016) Intracerebroventricular administration of alpha-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats. Metab Brain Dis 31:377\u2013383. doi: 10.1007\/s11011-015-9768-8","journal-title":"Metab Brain Dis"},{"key":"35_CR82","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/j.1460-9568.2004.03246.x","volume":"19","author":"A Wu","year":"2004","unstructured":"Wu A, Ying Z, Gomez-Pinilla F (2004) The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 19:1699\u20131707. doi: 10.1111\/j.1460-9568.2004.03246.x","journal-title":"Eur J Neurosci"},{"key":"35_CR83","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1046\/j.1471-4159.1994.63041508.x","volume":"63","author":"M Yudkoff","year":"1994","unstructured":"Yudkoff M, Daikhin Y, Nissim I, Pleasure D, Stern J, Nissim I (1994) Inhibition of astrocyte glutamine production by alpha-ketoisocaproic acid. J Neurochem 63:1508\u20131515","journal-title":"J Neurochem"},{"key":"35_CR84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0197-4580(99)00049-4","volume":"20","author":"L Zhang","year":"1999","unstructured":"Zhang L, Jope RS (1999) Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiol Aging 20:271\u2013278","journal-title":"Neurobiol Aging"},{"key":"35_CR85","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0197-0186(01)00077-8","volume":"40","author":"HR Zielke","year":"2002","unstructured":"Zielke HR, Zielke CL, Baab PJ, Collins RM (2002) Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria. Neurochem Int 40:347\u2013354","journal-title":"Neurochem Int"},{"key":"35_CR86","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/brain\/awp024","volume":"132","author":"WJ Zinnanti","year":"2009","unstructured":"Zinnanti WJ et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132:903\u2013918. doi: 10.1093\/brain\/awp024","journal-title":"Brain"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-017-0035-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-0035-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-0035-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:24:45Z","timestamp":1659047085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-017-0035-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,27]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s11011-017-0035-z","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,27]]}}}